Search

Your search keyword '"Joerg Koglin"' showing total 36 results

Search Constraints

Start Over You searched for: Author "Joerg Koglin" Remove constraint Author: "Joerg Koglin" Search Limiters Full Text Remove constraint Search Limiters: Full Text
36 results on '"Joerg Koglin"'

Search Results

1. Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension

2. Renal function and the effects of vericiguat in patients with worsening heart failure with reduced ejection fraction

3. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator

4. Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial

5. CORONARY ARTERY DISEASE AND CARDIOVASCULAR OUTCOMES IN HEART FAILURE: INSIGHTS FROM THE VERICIGUAT GLOBAL STUDY IN SUBJECTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION (VICTORIA) TRIAL

6. BASELINE CARDIAC TROPONIN T, CLINICAL OUTCOMES AND VERICIGUAT TREATMENT EFFECT IN HEART FAILURE WITH REDUCED EJECTION FRACTION STUDY: INSIGHTS FROM THE VICTORIA TRIAL

7. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator: The VICTORIA Trial

8. Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document

9. Reassessing Phase II Heart Failure Clinical Trials: Consensus Recommendations

10. Association between sitagliptin use and heart failure hospitalization and related outcomes in type 2 diabetes mellitus: secondary analysis of a randomized clinical trial

11. Chronic Arterial Responses to Overlapping Paclitaxel-Eluting Stents

12. Effect of the polymer-based, paclitaxel-eluting TAXUS Express stent on vascular tissue responses: a volumetric intravascular ultrasound integrated analysis from the TAXUS IV, V, and VI trials

13. Polymer-Based, Paclitaxel-Eluting TAXUS Liberté Stent in De Novo Lesions

14. Incidence, Timing, and Correlates of Stent Thrombosis With the Polymeric Paclitaxel Drug-Eluting Stent

15. Two-Year Serial Coronary Angiographic and Intravascular Ultrasound Analysis of In-Stent Angiographic Late Lumen Loss and Ultrasonic Neointimal Volume from the TAXUS II Trial

16. Clinical Efficacy of Polymer-Based Paclitaxel-Eluting Stents in the Treatment of Complex, Long Coronary Artery Lesions From a Multicenter, Randomized Trial

17. Expansion of Circulating Toll-Like Receptor 4–Positive Monocytes in Patients With Acute Coronary Syndrome

18. Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation

19. Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation

20. Peristent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation - Insights from serial intravascular ultrasound analysis in the TAXUS II study

21. Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges

22. Carotid Atherosclerosis Progression in Familial Hypercholesterolemia Patients A Pooled Analysis of the ASAP, ENHANCE, RADIANCE 1, and CAPTIVATE Studies

23. Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial

24. Abstract 2357: Effect of Prolonged Thienopyridine Use on Long-term Clinical Outcomes After Drug-eluting Stents: Landmark Analysis from the TAXUS Trials

25. Abstract 2153: Taxus Atlas Long Lesion: First Report of 9-Month Clinical and Angiographic Outcomes for the TAXUS Liberté 38 mm Stent for Long Lesions

26. Safety and efficacy of multiple, overlapping polymer-based paclitaxel-eluting stents

27. Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation

28. Polymer-based, paclitaxel-eluting TAXUS Liberté stent in de novo lesions: the pivotal TAXUS ATLAS trial

29. An overview of the TAXUS Express, paclitaxel-eluting stent clinical trial program

30. Incidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent: a TAXUS II, IV, V, and VI meta-analysis of 3,445 patients followed for up to 3 years

31. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial

32. Enhanced T-helper-1 lymphocyte activation patterns in acute coronary syndromes

33. 1059-5 TAXUS IV diabetic subset analysis: Improvements in nine-month outcomes in diabetics on oral medication as well as insulin

34. 1059-7 Impact of late loss on clinical, angiographic and intravascular ultrasound outcomes in the TAXUS IV trial

Catalog

Books, media, physical & digital resources